2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 18.723 | 14.363 | 14.222 | 13.076 | 29.236 | 32.326 | 24.363 | - | 34.640 | 21.733 |
Total Income - EUR | 18.723 | 14.363 | 14.222 | 13.076 | 29.236 | 32.350 | 24.372 | - | 34.640 | 21.733 |
Total Expenses - EUR | 914 | 401 | 1.639 | 949 | 3.147 | 6.612 | 2.877 | - | 31.154 | 24.862 |
Gross Profit/Loss - EUR | 17.809 | 13.962 | 12.582 | 12.128 | 26.090 | 25.738 | 21.496 | - | 3.486 | -3.129 |
Net Profit/Loss - EUR | 17.247 | 13.690 | 12.188 | 11.735 | 25.129 | 24.768 | 20.915 | - | 2.498 | -3.527 |
Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 |
Check the financial reports for the company - Cardiovad Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 7.572 | 7.635 | 7.056 | 7.429 | 7.293 | 7.152 | 7.016 | - | 57.120 | 90.005 |
Current Assets | 41.948 | 56.123 | 68.552 | 78.384 | 23.360 | 43.088 | 63.202 | - | 76.896 | 10.313 |
Inventories | 0 | 0 | 0 | 0 | 0 | 364 | 0 | - | 0 | 0 |
Receivables | 5.460 | 2.678 | 3.598 | 9.547 | 3.176 | 2.249 | 2.603 | - | 11.441 | 0 |
Cash | 36.488 | 53.445 | 64.953 | 68.837 | 20.184 | 40.475 | 60.600 | - | 65.455 | 10.313 |
Shareholders Funds | 49.514 | 63.701 | 75.239 | 85.701 | 25.450 | 49.726 | 69.698 | - | 104.161 | 100.318 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | - | 41 | 40 |
Debts | 6 | 58 | 369 | 112 | 5.203 | 514 | 521 | - | 29.855 | 0 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8512 - 8512" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Cardiovad Srl